What is the official ID of this bill?
The official print number for this legislation is HR 5924.
Earlier Medicare Drug Cost Reductions and Price Negotiations
This bill accelerates changes in the Medicare program aimed at reducing drug costs for citizens. This means that out-of-pocket drug spending limits will be lowered sooner, and the government will begin negotiating drug prices with pharmaceutical companies earlier than originally planned. The goal is to reduce the financial burden of prescription drug purchases for Medicare beneficiaries.
Key points
The annual out-of-pocket drug spending cap in Medicare will be lowered sooner, potentially meaning lower costs for patients as early as 2023 and 2024.
The government will begin negotiating drug prices with pharmaceutical companies in 2024, instead of 2026, which may lead to faster reductions in the cost of some medications.
The changes aim to accelerate access to more affordable drugs for millions of Americans covered by Medicare.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.